Metopole 25 Tablet contains Metoprolol Tartrate 25 mg, a cardioselective beta-1 adrenergic receptor blocker primarily used in the management of cardiovascular conditions. It is indicated for the treatment of hypertension, angina pectoris, and heart failure, as well as for the prevention of myocardial infarction and in the management of certain arrhythmias. Metoprolol Tartrate acts by selectively blocking beta-1 receptors in the heart, leading to a decrease in heart rate, myocardial contractility, and cardiac output, thereby reducing oxygen demand and lowering blood pressure. This mechanism helps in controlling symptoms associated with elevated sympathetic activity and improves survival rates post-myocardial infarction. The tablet is typically administered orally, with dosage individualized based on the patient’s clinical response and tolerability. Common side effects may include fatigue, dizziness, bradycardia, and gastrointestinal disturbances. Caution is advised in patients with asthma, diabetes, or peripheral vascular disease due to potential adverse effects. Metopole 25 should be used under medical supervision, with gradual dose adjustments to minimize withdrawal symptoms. Regular monitoring of blood pressure, heart rate, and cardiac function is recommended to ensure therapeutic efficacy and safety.